AMED stock news

Amedisys (AMED) is currently enjoying investors' confidence, thanks to solid prospects. Read more
Is (AMED) Outperforming Other Medical Stocks This Year? Read more
Is (AMED) Outperforming Other Medical Stocks This Year? Read more

Moving Average Crossover Alert: Amedisys

12:09pm, Wednesday, 14'th Aug 2019
Amedisys, Inc. (AMED) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front. Read more
Amedisys (AMED) possesses solid growth attributes, which could help it handily outperform the market. Read more
Zacks.com featured highlights include: Marine Products, Amedisys, Universal Forest Products, NVR and AllianceBernstein Read more
Robust year-over-year growth in Medicare and non-Medicare revenues aids Amedisys' (AMED) Home Health and Hospice divisions. Read more
Amedisys (AMED) delivered earnings and revenue surprises of 24.74% and 0.40%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock? Read more
The Zacks Analyst Blog Highlights: M.D.C., Amedisys, KBR, Holly Energy and SkyWest Read more
Zacks.com featured highlights include: Amedisys, AbbVie, Laureate, Genesco and Valeritas Read more
Amedisys (AMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Read more
Within Home Health, Amedisys (AMED) is expected to boost same-store volumes in Q2 via higher admissions and re-certifications. Read more
Zacks.com featured highlights include: Ross Stores, Shoe Carnival, Stitch Fix, Amedisys and NVR Read more
Amedisys (AMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. Read more
Amedisys' (AMED) recently-integrated Personal Care segment is attaining stability and living up to expectation. Read more

Proudly made at

ROCKIT